다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Dermatologic therapy, v.24 no.1, 2011년, pp.54 - 61
Hexsel, Camile (Department of Dermatology, Henry Ford Hospital, Detroit, Michigan) , Hexsel, Doris (Brazilian Center for Studies in Dermatology and) , Porto, Manoela Donida (Brazilian Center for Studies in Dermatology and) , Schilling, Juliana (Brazilian Center for Studies in Dermatology and) , Siega, Carolina (Brazilian Center for Studies in Dermatology and)
AI-Helper
ABSTRACTBotulinum neurotoxin type A injection to correct and/or reverse the physical effects of aging process has become one of the most frequently requested cosmetic procedures at an outpatient setting. Careful clinical evaluation together with proper use of the techniques, including pre‐ and...
Carruthers Botulinum toxin in facial rejuvenation: an update Dermatol Clin 2009 10.1016/j.det.2009.08.001 27 4 417
Brandt Randomized, placebo-controlled study of a new botulinum toxin type a for treatment of glabellar lines: efficacy and safety Dermatol Surg 2009 10.1111/j.1524-4725.2009.01235.x 35 12 1893
Hexsel Surgery of the skin - procedural dermatology 2010 433
Wu Botulinum toxin type A for the treatment of glabellar lines in Chinese: a double-blind, randomized, placebo-controlled study Dermatol Surg 2010 10.1111/j.1524-4725.2009.01390.x 36 1 102
Ascher Efficacy and safety of botulinum toxin type A in the treatment of lateral crow's feet: double-blind, placebo-controlled, dose-ranging study Dermatol Surg 2009 10.1111/j.1524-4725.2009.01261.x 35 10 1478
Naumann Safety and efficacy of botulinum toxin type A following long-term use Eur J Neurol 2006 10.1111/j.1468-1331.2006.01652.x 13 4 35
Kim Botulinum toxin: a treatment for compensatory hyperhidrosis in the trunk Dermatol Surg 2009 10.1111/j.1524-4725.2009.01140.x 35 5 833
Benedetto Asymmetrical smiles corrected by botulinum toxin serotype A Dermatol Surg 2007 10.1111/j.1524-4725.2006.32329.x 33 1 S32
Carruthers Advances in facial rejuvenation: botulinum toxin type a, hyaluronic acid dermal fillers, and combination therapies - consensus recommendations Plast Reconstr Surg 2008 10.1097/PRS.0b013e31816de8d0 121 5 5S
Ascher International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood unit) - part I: upper facial wrinkles J Eur Acad Dermatol Venereol 2010 10.1111/j.1468-3083.2010.03631.x 24 11 1278
Ascher International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood unit) - part II: wrinkles on the middle and lower face, neck and chest J Eur Acad Dermatol Venereol 2010 10.1111/j.1468-3083.2010.03728.x 24 11 1285
Sattler Patient management and treatment technique Clin Dermatol 2003 10.1016/j.clindermatol.2003.11.012 21 485
Pena Complications with the use of botulinum toxin type A for cosmetic applications and hyperhidrosis Semin Cutan Med Surg 2007 10.1016/j.sder.2006.12.004 26 1 29
Weiss Reduction of pain and anxiety prior to botulinum toxin injections with a new topical anesthetic method Ophthal Plast Reconstr Surg 2009 10.1097/IOP.0b013e3181a145ca 25 3 173
Wollina Managing adverse events associated with botulinum toxin type-A: a focus on cosmetic procedures Am J Clin Dermatol 2005 10.2165/00128071-200506030-00001 6 3 141
Hexsel Multicenter, double-blind study of the efficacy of injections with botulinum toxin type A reconstituted up to six consecutive weeks before application Dermatol Surg 2003 10.1046/j.1524-4725.2003.29121.x 29 523
Hexsel Re: Hexsel et al. Multicenter, double-blind study of the efficacy of injections with botulinum toxin a reconstituted up to six consecutive weeks before application Dermatol Surg 2004 10.1111/j.1524-4725.2004.30228.x 30 823
Hexsel Blind multicenter study of the efficacy and safety of injections of a commercial preparation of botulinum toxin type A reconstituted up to 15 days before injection Dermatol Surg 2009 10.1111/j.1524-4725.2009.01158.x 35 933
Karsai Current evidence on the unit equivalence of different botulinum neurotoxin A formulations and recommendations for clinical practice in dermatology Dermatol Surg 2009 10.1111/j.1524-4725.2008.34375.x 35 1 1
Karsai Do different formulations of botulinum toxin type A really have different migration characteristics? J Cosmet Dermatol 2008 10.1111/j.1473-2165.2008.00395.x 7 3 230
Hexsel A randomized pilot study comparing the action halos of two commercial preparations of botulinum toxin type A Dermatol Surg 2008 10.1111/j.1524-4725.2007.34008.x 34 1 52
Carruthers A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines J Am Acad Dermatol 2002 10.1067/mjd.2002.121356 46 840
Ascher A multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines J Am Acad Dermatol 2004 10.1016/j.jaad.2003.11.084 51 223
Monheit A randomized, double-blind, placebo-controlled study of botulinum toxin type A for the treatment of glabellar lines: determination of optimal dose Dermatol Surg 2007 10.1111/j.1524-4725.2006.32332.x 33 1 51
Karsai Botox and Dysport: is there a dose conversion ratio in dermatology and aesthetic medicine? J Am Acad Dermatol 2010 10.1016/j.jaad.2008.12.028 62 2 346
Price Needle preference in patients receiving cosmetic botulinum toxin type A Dermatol Surg 2010 10.1111/j.1524-4725.2009.01391.x 36 1 109
Rzany Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region Arch Dermatol 2006 10.1001/archderm.142.3.320 142 3 320
Benedetto The cosmetic uses of botulinum toxin type A Int J Dermatol 1999 10.1046/j.1365-4362.1999.00722.x 38 641
Hexsel Textbook of cosmetic dermatology 2005 707
Carruthers Eyebrow height after botulinum toxin type A to the glabella Dermatol Surg 2007 10.1111/j.1524-4725.2006.32328.x 33 1 S26
Hexsel Cosmetic medicine and aesthetic surgery. Strategies for success 2009 285
Klein Contraindications and complications with the use of botulinum toxin Clin Dermatol 2004 10.1016/j.clindermatol.2003.12.026 22 66
Carruthers Botulinum toxin type A: history and current cosmetic use in the upper face Dis Mon 2002 10.1053/mda.2001.25138 48 5 299
Hexsel Cosmetic use of botulinum toxin 2002 233
Carruthers Aesthetic botulinum A toxin in the mid and lower face and neck Dermatol Surg 2003 10.1046/j.1524-4725.2003.29115.x 29 468
Flynn Botulinum-A toxin treatment of the lower eyelid improves infraorbital rhytides and widens the eye Dermatol Surg 2001 10.1046/j.1524-4725.2001.01038.x 27 8 703
Carruthers The adjunctive usage of botulinum toxin Dermatol Surg 1998 10.1016/S1076-0512(98)00188-5 24 1244
Mazzuco Cosmetic use of botulinum toxin 2002 158
Carruthers Consensus recommendations on the use of botulinum toxin type A in face aesthetics Plast Reconstr Surg 2004 10.1097/01.PRS.0000144795.76040.D3 114 6 1S
Coscarelli Cosmetic use of botulinum toxin 2002 198
De Sa Earp The five D's of botulinum toxin: doses, dilution, diffusion, duration and dogma J Cosmet Laser Ther 2008 10.1080/14764170701883660 10 2 93
Becker-Wegerich Botulinum toxin A: successful décolleté rejuvenation Dermatol Surg 2002 10.1046/j.1524-4725.2002.01116.x 28 168
Isaac Cosmetic use of botulinum toxin 2002 178
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.